Across a large British study of nearly half a million adults, a quiet pattern has emerged: those who take a moderate daily cup of coffee appear less likely to develop chronic liver disease, or to die from it, than those who never drink it. The finding, drawn from the UK Biobank and published in BMC Public Health, reminds us how ordinary habits can carry unexpected weight in the long arc of human health. Yet the researchers are careful to note that observation is not the same as proof, and that the people studied, largely white and well-off, may not stand for everyone.
Coffee Linked to Lower Risk of Chronic Liver Disease, UK Biobank Study Finds
The benefit peaked at three to four cups a day.
Mark
The headline number is 49 per cent lower risk of death from chronic liver disease. Why does that stand out?
Mimi
It's the largest of the three figures, set against 21 per cent for chronic liver disease and 20 per cent for chronic or fatty liver disease. And it held for decaf too, so it isn't just about caffeine.
Mark
Ground coffee showed the strongest link. Is there an explanation?
Mimi
The researchers point to kahweol and cafestol, which are high in ground coffee and have been shown to help against chronic liver disease in animals.
Luke
Animals, though. That's a proposed mechanism, not something this study demonstrated in people.
Mark
Instant coffee is low in those compounds but still showed a link. What does that suggest?
Mimi
The study suggests other ingredients, or a combination of them, may be doing something. The reduction was smaller than for ground coffee.
Luke
And that's a suggestion. Nothing here identifies which ingredient matters.
Mark
Dr Kennedy talks about coffee as a potential preventative treatment. Is that established?
Luke
No. It's observational, so it shows an association, not cause. His wording is "potential" and "may," and that's about right.
Mimi
The authors also note coffee intake was recorded only at enrolment, and participants were mostly white and better off.
Luke
So we don't know if people's habits changed over 10.7 years, and we can't say the result applies broadly. Further testing is what the authors themselves call for.
Der Puls
- Nearly 500,000 UK participants were tracked for about a decade, and the coffee drinkers showed a steady edge against liver disease.
- Risk of chronic liver disease ran 21 per cent lower among those drinking up to four cups a day, and liver-related deaths fell by nearly half.
- The protective effect rose and peaked around three to four cups, with ground coffee showing the clearest benefit and instant coffee a smaller one.
- Coffee was recorded only once at enrolment, and the cohort skewed white and affluent, so the promise remains untested beyond its original frame.
Across a large British study of nearly half a million adults, a quiet pattern has emerged: those who take a moderate daily cup of coffee appear less likely to develop chronic liver disease, or to die from it, than those who never drink it. The finding, drawn from the UK Biobank and published in BMC Public Health, reminds us how ordinary habits can carry unexpected weight in the long arc of human health. Yet the researchers are careful to note that observation is not the same as proof, and that the people studied, largely white and well-off, may not stand for everyone.
A large study drawing on data from 495,585 people in the UK Biobank has found that people who drink coffee, up to about four cups a day, were less likely to develop chronic liver disease than those who drink none. The work, led by researchers at the Universities of Southampton and Edinburgh, appears in the journal BMC Public Health.
The association held whether the coffee was caffeinated or decaffeinated. Coffee drinkers showed a 21 per cent lower risk of chronic liver disease, and their risk of dying from it was 49 per cent lower. The benefit was greatest at three to four cups a day. Over a median follow-up of 10.7 years, the team tracked thousands of cases, including hundreds of deaths.
The strongest link appeared among those who drank ground coffee, which carries higher levels of compounds that have shown protective effects against liver disease in animal studies. Instant coffee, lower in those compounds, also showed a benefit, though a smaller one, suggesting other ingredients may contribute.
Lead author Dr Oliver Kennedy suggested that coffee, being widely available, might one day serve as a low-cost preventive measure, particularly in lower-income countries where liver disease weighs most and healthcare is hardest to reach. The authors, however, are clear about the limits: coffee habits were recorded only once, and the participants were mostly white and from higher socio-economic backgrounds. Future research, they say, must test these links more tightly and in far more diverse populations.
A study drawing on data from 495,585 people in the UK Biobank has found that those who drink coffee, up to about four cups a day, were less likely to develop chronic liver disease than those who drink none. The work, by researchers at the Universities of Southampton and Edinburgh, is published in the journal BMC Public Health.
The association held for both caffeinated and decaffeinated coffee. Compared with people who did not drink coffee, coffee drinkers had a 21 per cent lower risk of chronic liver disease and a 20 per cent lower risk of chronic liver disease or fatty liver disease. Their risk of dying from chronic liver disease was 49 per cent lower. The benefit peaked at three to four cups a day.
The researchers followed participants for a median of 10.7 years. Of those included, 78 per cent, or 384,818 people, drank ground or instant coffee, caffeinated or decaffeinated. The other 22 per cent, or 109,767 people, drank no coffee at all. Over the study period there were 3,600 cases of chronic liver disease, including 301 deaths. There were also 5,439 cases of chronic liver disease or steatosis, a build-up of fat in the liver also known as fatty liver disease, and 184 cases of hepatocellular carcinoma, a type of liver cancer.
The strongest link was seen among people who drank ground coffee, which contains high levels of two compounds, kahweol and cafestol. Both have been shown to be beneficial against chronic liver disease in animals, the researchers say. Instant coffee, which is low in those compounds, was also associated with a lower risk. The reduction was smaller than for ground coffee, which the study suggests may mean other ingredients, or a combination of them, play a part.
Dr Oliver Kennedy, the lead author, said coffee is widely accessible and that the findings may mean it could offer a potential preventative treatment for chronic liver disease. He said this would be especially valuable in lower-income countries with worse access to healthcare, where the burden of the disease is highest.
The authors set out clear limits. Coffee consumption was recorded only once, when participants enrolled, so the study cannot account for changes in how much or what type of coffee people drank over the following 10.7 years. Participants were also predominantly white and from higher socio-economic backgrounds, so the findings may not translate easily to other countries and populations.
The researchers suggest future work could test the relationship between coffee and liver disease with tighter control over how much coffee is consumed, and that the findings should be validated in more diverse groups of participants.
Bemerkenswerte Zitate
Coffee is widely accessible and the benefits seen may mean it could offer a potential preventative treatment for chronic liver disease, especially valuable in lower-income countries.— Dr Oliver Kennedy, lead author
Möchten Sie die ganze Geschichte?
Das Original lesen bei BreakingNews.ie ↗
Science & Space